fluorodeoxyglucose f18 has been researched along with glyx-13 peptide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Miao, C; Sun, P; Wu, Q; Zhao, Y; Zhu, M | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and glyx-13 peptide
Article | Year |
---|---|
Propofol Disrupts Aerobic Glycolysis in Colorectal Cancer Cells via Inactivation of the NMDAR-CAMKII-ERK Pathway.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Tumor; Colorectal Neoplasms; Dizocilpine Maleate; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glycolysis; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Oligopeptides; Phosphoglycerate Kinase; Prognosis; Propofol; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2018 |